Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Modality (Veno -Arterial (VA), Veno -Venous (VV), Arterio-Venous (AV)), by Application (Respiratory, Cardiac, ECPR), by Geography - Global Forecast to 2020

体外式膜型人工肺(ECMO)療法装置の世界市場

◆タイトル:Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Modality (Veno -Arterial (VA), Veno -Venous (VV), Arterio-Venous (AV)), by Application (Respiratory, Cardiac, ECPR), by Geography - Global Forecast to 2020
◆商品コード:MAM-MD-3966
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年12月15日
◆ページ数:139
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、体外式膜型人工肺(ECMO)療法装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、方式別分析、用途別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・市場インサイト
・市場概観/市場動向
・体外式膜型人工肺(ECMO)療法装置の世界市場:方式別分析/市場規模
・体外式膜型人工肺(ECMO)療法装置の世界市場:用途別分析/市場規模
・体外式膜型人工肺(ECMO)療法装置の世界市場:地域別分析/市場規模
・体外式膜型人工肺(ECMO)療法装置のアジア市場規模予測
・体外式膜型人工肺(ECMO)療法装置のヨーロッパ市場規模予測
・体外式膜型人工肺(ECMO)療法装置のアメリカ市場規模予測
・体外式膜型人工肺(ECMO)療法装置の世界市場動向
・競争状況
・関連企業分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

The Global Extracorporeal Membrane Oxygenation (ECMO) System market report is analysed and segmented on the basis of modality, application, and region. It analyzes the competitive developments, such as alliance, joint venture, and merger & acquisition in the global extracorporeal membrane oxygenation (ECMO) system market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments.

Extracorporeal membrane oxygenation (ECMO) can be a lifesaving therapy in patients with refractory severe respiratory failure or cardiac failure. The device is combination of one membrane oxygenator, cannula, oxygen blender, heat exchanger, post membrane pressure monitor, venous reservoir and centrifugal pump.

Increasing number of patients suffering from respiratory failure and cardiopulmonary disease, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), increasing adoption rate of ECMO machine in hospitals, technological advancement in ECMO system, success rate of ECMO & government initiatives, and growing awareness towards ECMO are major factors propelling the market towards growth.

The usage of ECMO for respiratory failure has been increasing since 2009. The device has its utility to stabilize gas exchange and hemodynamic compromise, consequently preventing further hypoxic organ damage. Furthermore, ECMOs are largely used to improve severe acute respiratory distress syndrome (ARDS), which has a high-mortality rate. When conventional therapy cannot maintain adequate oxygenation, initiation of ECMO for an adult with ARDS should be considered.

The global extracorporeal membrane oxygenation (ECMO) system market was USD 227.7 Million in 2014 and is expected to reach USD 287.6 Million by 2020 at a CAGR of 4.0% from 2015 to 2020.

The ECMO system is broadly segmented on the basis of mortality and application. Based on mortality, the global extracorporeal membrane oxygenation (ECMO) system market is classified into Veno-Arterial (VA), Veno-Venous (VV), and Artrio-Venous (AV). Veno-arterial ECMO provides support to lungs and heart, and it is the most preferred method. The VA ECMO contributes the largest share in the EMCO market, by modality.

However, a shift in the usage pattern is witnessed in Europe, wherein veno-venous modality is frequently used as it does not shunt the carotid artery, as opposed to VA procedure.

Based on application, the extracorporeal membrane oxygenation (ECMO) system can be segmented into respiratory indications, cardiac indications, and extra-corporeal cardiopulmonary resuscitation (ECPR). The respiratory segment contributes to the largest share followed by the cardiac indications. Today, the applications of ECMO is increasing in patients considering the cardiac conditions. The ratio of usage of ECMO in cardiac indication and respiratory indication would be similar.

The report provides a detailed analysis of ECMO systems market for each region and country. Four major regions covered in the report are North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, Spain, Switzerland and the U.K.), Asia-Pacific (Japan, China, India, Australia, Republic of Korea and Rest of Asia-Pacific), and Rest of the World. A deep-dive analysis on pricing pattern, usage pattern, end user response matrix, market share, government initiatives, product recalls, new product launches, industry trends, and technological advancements have been detailed in the report.

The report also covers the competitive landscape of global extracorporeal membrane oxygenation (ECMO) system market by new product launches, recent developments, and mergers & acquisitions. The major players operating in this market are MAQUET Holding B.V. & CO. KG. (Germany), SORIN Group (Italy), MEDTRONIC (Republic of Ireland), NIPRO Medical Corporation (U.S.), Terumo Medical Corporation (Japan), MicroPort Scientific Corporation (China), Medos Medizintechnik AG (Germany).

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Integrated Ecosystem of the Market
2.2 Arriving at the Market Size
2.2.1 Top-Down Approach
2.2.2 Macro Indicator- Based Approach
2.3 Price Analysis of Extra Corporeal Membrane Oxygenation Systems Market, By Product
2.4 Assumptions

3 Executive Summary (Page No. – 25)

4 Market Overview (Page No. – 28)
4.1 Market Drivers and Inhibitors
4.2 Threats of Ecmo
4.3 Opportunities in Future

5 Extracorporeal Membrane Oxygenation Systems Market, By Modality (Page No. – 32)
5.1 Introduction
5.2 Veno-Arterial
5.3 Veno-Venous
5.4 Arterio-Venous (AV)

6 Extracorporeal Membrane Oxygenation Systems Market, By Application (Page No. – 38)
6.1 Introduction
6.2 Respiratory
6.2.1 Neonates
6.2.2 Pediatric
6.2.3 Adult
6.3 Cardiac
6.3.1 Neonates
6.3.2 Pediatric
6.3.3 Adult
6.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
6.4.1 Neonates
6.4.2 Pediatric
6.4.3 Adult

7 Extracorporeal Membrane Oxygenation Systems Market, By Geography (Page No. – 47)
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Switzerland
7.3.7 Rest of Europe (RoE)
7.4 Asia-Pacific (APAC)
7.4.1 Japan
7.4.2 Australia
7.4.3 China
7.4.4 India
7.4.5 Singapore
7.4.6 Republic of Korea
7.4.7 Rest of Asia-Pacific
7.5 Rest of the World (RoW)

8 Competitive Landscape (Page No. – 113)
8.1.1 New Product Launch & Product Development
8.1.2 Agreement, Acquisition & Partnership
8.1.3 Expansion
8.1.4 Other

9 Company Profiles (Page No. – 118)
9.1 Maquet Holding B.V. & Co. Kg.
9.1.1 Overview
9.1.2 Key Financials
9.1.3 Product and Service Offerings
9.1.4 Related Developments
9.1.5 MnM View
9.2 Medtronic, Inc. (U.S.)
9.2.1 Overview
9.2.2 Key Financials
9.2.3 Product and Service Offerings
9.2.4 Related Developments
9.2.5 MnM View
9.3 Microport Scientific Corporation
9.3.1 Overview
9.3.2 Key Financials
9.3.3 Product and Service Offerings
9.3.4 MnM View
9.4 Terumo Cardiovascular Systems Corporation
9.4.1 Overview
9.4.2 Key Financials
9.4.3 Product and Service Offerings
9.4.4 Related Developments
9.4.5 MnM View
9.5 Medos Medizintechnik AG
9.5.1 Overview
9.5.2 Product and Service Offerings
9.5.3 Related Developments
9.5.4 MnM View
9.6 Nipro Medical Corporation
9.6.1 Overview
9.6.2 Key Financials
9.6.3 Product and Service Offerings
9.6.4 Related Developments
9.6.5 MnM View
9.7 Sorin Group (Sorin S.P.A.)
9.7.1 Overview
9.7.2 Sorin Group: Key Financials
9.7.3 Product and Service Offerings
9.7.4 Related Developments
9.7.5 MnM View

10 Appendix (Page No. – 136)
10.1 Introducing Rt: Real-Time Market Intelligence
10.2 Customization Options
10.2.1 Product Analysis
10.2.2 Pulmonologist/Physicians Perception Analysis
10.2.3 Regulatory Framework
10.2.4 Competitive Intelligence
10.3 Related Reports

List of Tables (78 Tables)

Table 1 Extracorporeal Membrane Oxygenation Systems Market: Macro Indicators, By Country, 2014 (USD Million)
Table 2 Market: Drivers and Inhibitors
Table 3 Extracorporeal Membrane Oxygenation (ECMO) Market, By Modality, 2013-2020 (USD Million)
Table 4 Veno-Arterial Market, By Geography, 2013–2020 (USD Million)
Table 5 Veno-Venous Market, By Geography, 2013–2020 (USD Million)
Table 6 Arterio-Venous Extracorporeal Membrane Oxygenation Market, By Geography, 2013–2020 (USD Million)
Table 7 Market, By Application, 2013-2020 (USD Million)
Table 8 Market in Respiratory Application, By Age Group, 2013-2020 (USD Million)
Table 9 Market in Cardiac Application, By Age Group, 2013-2020 (USD Million)
Table 10 Market in ECPR, By Age Group, 2013-2020 (USD Million)
Table 11 Market, By Geography, 2013-2020 (USD Million)
Table 12 North America: Market, By Modality, 2013-2020 (USD Million)
Table 13 North America: Market, By Application, 2013-2020 (USD Million)
Table 14 North America: Market in Respiratory Application, By Age Group, 2013-2020 (USD Million)
Table 15 North America: Market in Cardiac Application, By Age Group, 2013-2020 (USD Million)
Table 16 North America: Market in ECPR Application, By Age Group, 2013-2020 (USD Million)
Table 17 U.S.: Market, By Modality, 2013-2020 (USD Million)
Table 18 U.S.: Extra Corporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 19 Canada: Market, By Modality, 2013-2020 (USD Million)
Table 20 Canada: Extracorporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 21 Mexico: Market, By Modality, 2013-2020 (USD Million)
Table 22 Mexico: Extracorporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 23 Europe: Market, By Modality, 2013-2020 (USD Million)
Table 24 Europe: Extracorporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 25 Europe: Market in Respiratory Application, By Age Group, 2013-2020 (USD Million)
Table 26 Europe: Market in Cardiac Application, By Age Group, 2013-2020 (USD Million)
Table 27 Europe: Market in ECPR Application, By Age Group, 2013-2020 (USD Million)
Table 28 Germany: Market, By Modality, 2013-2020 (USD Million)
Table 29 Germany: Extracorporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 30 U.K.: Market, By Modality, 2013-2020 (USD Million)
Table 31 U.K.: Market, By Application, 2013-2020 (USD Million)
Table 32 France: Market, By Modality, 2013-2020 (USD Million)
Table 33 France: Market, By Application, 2013-2020 (USD Million)
Table 34 Italy: Market, By Modality, 2013-2020 (USD Million)
Table 35 Italy: Extracorporeal Membrane Oxygenation Market, By Application, 2013-2020 (USD Million)
Table 36 Spain: Extra Corporeal Membrane Oxygenation Systems Market, By Modality, 2013-2020 (USD Million)
Table 37 Spain: Market, By Application, 2013-2020 (USD Million)
Table 38 Switzerland: Market, By Modality, 2013-2020 (USD Million)
Table 39 Switzerland: Market, By Application, 2013-2020 (USD Million)
Table 40 RoE: Extra Corporeal Membrane Oxygenation Systems Market, By Modality, 2013-2020 (USD Million)
Table 41 RoE: Market, By Application, 2013-2020 (USD Million)
Table 42 APAC: Market, By Modality, 2013-2020 (USD Million)
Table 43 APAC: Market, By Application, 2013-2020 (USD Million)
Table 44 APAC: Market in Respiratory Application, By Age Group, 2013-2020 (USD Million)
Table 45 APAC: Market in Cardiac Application, By Age Group, 2013-2020 (USD Million)
Table 46 APAC: Market in ECPR Application, By Age Group, 2013-2020 (USD Million)
Table 47 Japan: Market, By Modality, 2013-2020 (USD Million)
Table 48 Japan: Market, By Application, 2013-2020 (USD Million)
Table 49 Australia: Extra Corporeal Membrane Oxygenation Systems Market, By Modality, 2013-2020 (USD Million)
Table 50 Australia: Extra Corporeal Membrane Oxygenation Systems Market, By Application, 2013-2020 (USD Million)
Table 51 China: Market, By Modality, 2013-2020 (USD Million)
Table 52 China: Market, By Application, 2013-2020 (USD Million)
Table 53 India: Market, By Modality, 2013-2020 (USD Million)
Table 54 India: Extra Corporeal Membrane Oxygenation Systems Market, By Application, 2013-2020 (USD Million)
Table 55 Singapore: Market, By Modality, 2013-2020 (USD Million)
Table 56 Singapore: Market, By Application, 2013-2020 (USD Million)
Table 57 Republic of Korea: Market, By Modality, 2013-2020 (USD Million)
Table 58 Republic of Korea: Market, By Application, 2013-2020 (USD Million)
Table 59 Rest of APAC: Extra Corporeal Membrane Oxygenation Systems Market, By Modality, 2013-2020 (USD Million)
Table 60 Rest of APAC: Market, By Application, 2013-2020 (USD Million)
Table 61 RoW: Market, By Modality, 2013-2020 (USD Million)
Table 62 RoW: Market, By Application, 2013-2020 (USD Million)
Table 63 RoW: Market in Respiratory Application, By Age Group, 2013-2020 (USD Million)
Table 64 RoW: Market in Cardiac Application, By Age Group, 2013-2020 (USD Million)
Table 65 RoW: Market in ECPR Application, By Age Group, 2013-2020 (USD Million)
Table 66 Extra Corporeal Membrane Oxygenation System Market, By Company, 2014 (%)
Table 67 Maquet Holding B.V. & Co. Kg.: Key Financials, By Business Segment, 2012-2014 (USD MN)
Table 68 Maquet Holding B.V. & Co. Kg.: Key Financials, By Geography,2012-2014 (USD MN)
Table 69 Medtronic, Inc. : Key Financials, By Business Segment,2012-2014 (USD MN)
Table 70 Medtronic, Inc.: Key Financials, By Geography, 2012-2014 (USD MN)
Table 71 Microport Scientific Corporation: Key Financials, By Business Segment, 2012-2014 (USD MN)
Table 72 Microport Scientific Corporation: Key Financials, By Geography,2012-2014 (USD MN)
Table 73 Terumo Cardiovascular Systems Corporation: Key Financials, By Business Segment, 2012-2014 (USD MN)
Table 74 Terumo Cardiovascular Systems Corporation: Key Financials, By Geography, 2012-2014 (USD MN)
Table 75 Nipro Medical Corporation: Key Financials, By Business Segment,2011-2014 (USD MN)
Table 76 Sorin Group: Key Financials, By Business Segment, 2013-2014 (USD MN)
Table 77 Sorin Group: Key Financials (Cardiac Surgery), By Business Sub-Segment, 2013-2014 (USD MN)
Table 78 Sorin Group: Key Financials, By Geography, 2013-2014 (USD MN)

List of Figures (91 Figures)

Figure 1 Extracorporeal Membrane Oxygenation Systems Market Segmentation & Coverage
Figure 2 Market: Integrated Ecosystem
Figure 3 Arriving at the Market Size
Figure 4 Top-Down Approach
Figure 5 Macro Indicator-Based Approach
Figure 6 Market Snapshot
Figure 7 Extracorporeal Membrane Oxygenation Market, By Modality,2014 & 2020 (USD Million)
Figure 8 Veno-Arterial Extracorporeal Membrane Oxygenation Systems Market, By Geography, 2015 & 2020 (USD Million)
Figure 9 Veno-Venous Extracorporeal Membrane Oxygenation Systems Market, By Geography, 2015 & 2020 (USD Million)
Figure 10 Arterio-Venous Extracorporeal Membrane Oxygenation Market, By Geography, 2015 & 2020 (USD Million)
Figure 11 Indications Where ECMO is Used
Figure 12 Market, By Application, 2014 & 2020 (USD Million)
Figure 13 Market in Respiratory Application, By Age Group, 2015 & 2020 (USD Million)
Figure 14 Neonatal Survival Rate, Extracorporeal Life Support Organization (ELSO) Data (1987-1993)
Figure 15 Market in Cardiac Application, By Age Group, 2015 & 2020 (USD Million)
Figure 16 Market in ECPR, By Age Group, 2015 & 2020 (USD Million)
Figure 17 Extra Corporeal Membrane Oxygenation (ECMO): Growth Analysis, By Geography, 2014-2020 (USD Million)
Figure 18 North America: Market Overview, 2014 & 2020 (%)
Figure 19 North America: Market in Respiratory Application, By Age Group,2015 & 2020 (USD Million)
Figure 20 North America: Market in Cardiac Application, By Age Group, 2015 & 2020 (USD Million)
Figure 21 North America: Market in ECPR Application, By Age Group, 2015 & 2020 (USD Million)
Figure 22 U.S.: Market Overview, 2014 & 2020 (%)
Figure 23 U.S.: Market, By Modality, 2015 & 2020 (USD Million)
Figure 24 U.S.: Market, By Application, 2015 & 2020 (USD Million)
Figure 25 Canada: Market Overview, 2014 & 2020 (%)
Figure 26 Canada: Market, By Modality, 2015 & 2020 (USD Million)
Figure 27 Canada: Market, By Application, 2015 & 2020 (USD Million)
Figure 28 Mexico: Market Overview, 2014 & 2020 (%)
Figure 29 Mexico: Market, By Modality, 2015 & 2020 (USD Million)
Figure 30 Mexico: Market, By Application, 2015 & 2020 (USD Million)
Figure 31 Europe: Market Overview, 2014 & 2020 (%)
Figure 32 Europe: Market in Respiratory Application, By Age Group, 2015 & 2020 (USD Million)
Figure 33 Europe: Market in Cardiac Application, By Age Group, 2015 & 2020 (USD Million)
Figure 34 Europe: Market in ECPR Application, By Age Group, 2015 & 2020 (USD Million)
Figure 35 Germany: Market Overview, 2014 & 2020 (%)
Figure 36 Germany: Market, By Modality, 2015 & 2020 (USD Million)
Figure 37 Germany: Market, By Application, 2015 & 2020 (USD Million)
Figure 38 U.K.: Market Overview, 2014 & 2020 (%)
Figure 39 U.K.: Market, By Modality, 2015 & 2020 (USD Million)
Figure 40 U.K.: Market, By Application, 2015 & 2020 (USD Million)
Figure 41 France: Market Overview, 2014 & 2020 (%)
Figure 42 France: Market, By Modality, 2015 & 2020 (USD Million)
Figure 43 France: Market, By Application, 2015 & 2020 (USD Million)
Figure 44 Italy: Market Overview, 2014 & 2020 (%)
Figure 45 Italy: Market, By Modality, 2015 & 2020 (USD Million)
Figure 46 Italy: Market, By Application, 2015 & 2020 (USD Million)
Figure 47 Spain: Market Overview, 2014 & 2020 (%)
Figure 48 Spain: Market, By Modality, 2015 & 2020 (USD Million)
Figure 49 Spain: Market, By Application, 2015 & 2020 (USD Million)
Figure 50 Switzerland: Market Overview, 2014 & 2020 (%)
Figure 51 Switzerland: Market, By Modality, 2015 & 2020 (USD Million)
Figure 52 Switzerland: Market, By Application, 2015 & 2020 (USD Million)
Figure 53 RoE: Market Overview, 2014 & 2020 (%)
Figure 54 RoE: Market, By Modality, 2015 & 2020 (USD Million)
Figure 55 RoE: Market, By Application, 2015 & 2020 (USD Million)
Figure 56 APAC: Market Overview, 2014 & 2020 (%)
Figure 57 APAC: Extracorporeal Membrane Oxygenation Systems Market in Respiratory Application, By Age Group, 2015 & 2020 (USD Million)
Figure 58 APAC: Extracorporeal Membrane Oxygenation Systems Market in Cardiac Application, By Age Group, 2015 & 2020 (USD Million)
Figure 59 APAC: Extracorporeal Membrane Oxygenation Systems Market in ECPR Application, By Age Group, 2015 & 2020 (USD Million)
Figure 60 Japan: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 61 Japan: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 62 Japan: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 63 Australia: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 64 Australia: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 65 Australia: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 66 China: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 67 China: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 68 China: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 69 India: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 70 India: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 71 India: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 72 Singapore: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 73 Singapore: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 74 Singapore: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 75 Republic of Korea: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 76 Republic of Korea: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 77 Republic of Korea: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 78 Rest of APAC: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 79 Rest of APAC: Extracorporeal Membrane Oxygenation Systems Market, By Modality, 2015 & 2020 (USD Million)
Figure 80 Rest of APAC: Extracorporeal Membrane Oxygenation Systems Market, By Application, 2015 & 2020 (USD Million)
Figure 81 RoW: Extracorporeal Membrane Oxygenation Systems Market Overview, 2014 & 2020 (%)
Figure 82 RoW: Extracorporeal Membrane Oxygenation Systems Market in Respiratory Application, By Age Group, 2015 & 2020 (USD Million)
Figure 83 RoW: Extracorporeal Membrane Oxygenation Systems Market in Cardiac Application, By Age Group, 2015 & 2020 (USD Million)
Figure 84 RoW: Extracorporeal Membrane Oxygenation Systems Market in ECPR Application, By Age Group, 2015 & 2020 (USD Million)
Figure 85 Extracorporeal Membrane Oxygenation System Market, By Company, 2014 (%)
Figure 86 Maquet Holding B.V. & Co. Kg.: Revenue Mix, 2014 (%)
Figure 87 Medtronic, Inc.: Revenue Mix, 2014 (%)
Figure 88 Microport Scientific Corporation: Revenue Mix, 2014 (%)
Figure 89 Terumo Corporation: Revenue Mix, 2014 (%)
Figure 90 Nipro Medical Corporation: Revenue Mix, 2014 (%)
Figure 91 Sorin Group: Revenue Mix, 2014 (%)

【レポートのキーワード】

体外式膜型人工肺(ECMO)療法、エクモ装置、膜型人工肺、医療機器

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[体外式膜型人工肺(ECMO)療法装置の世界市場]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆